DeepMed Research

Medical University of South Carolina

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1955-01-01

Employees: 10K

Market Cap: -

Website: https://www.muschealth.com

Clinical Trials

Treatment of Alcohol Dependence and Comorbid Bipolar Disorder

Phase 4

Completed

Conditions: Depression
Mania
Psychosis
Bipolar Disorder
Alcohol Dependence

Interventions: Drug: Placebo
Drug: Lamotrigine

First Posted Date: 2009-11-18

Last Posted Date: 2019-01-09

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 43

Registration Number: NCT01015586

Locations: 🇺🇸
Clinical Neuroscience Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, United States

Investigation of Neuro-hormonal Mechanisms of Hunger, Fullness and Obesity.

Withdrawn

Conditions: Obesity
Gastric Emptying
Anxiety
Depression
Panic Disorder

First Posted Date: 2009-11-05

Last Posted Date: 2013-05-22

Lead Sponsor: Medical University of South Carolina

Registration Number: NCT01008371

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Sirolimus Conversions in African-American Renal Transplant Recipients

Not Applicable

Completed

Conditions: Absence; Kidney

Interventions: Drug: tacrolimus, sirolimus and steroid
Drug: rapamune, mycophenolate mofetil and steroid

First Posted Date: 2009-11-01

Last Posted Date: 2016-03-11

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 40

Registration Number: NCT01005706

Locations: 🇺🇸
The Medical University of South Carolina, Charleston, South Carolina, United States

A Trial of N-Acetylcysteine (an Over-the-Counter Medicine) in Adolescents Who Smoke Marijuana

Phase 2

Completed

Conditions: Cannabis Dependence

Interventions: Drug: placebo
Drug: N-Acetylcysteine
Behavioral: Contingency Management

First Posted Date: 2009-11-01

Last Posted Date: 2018-11-21

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 116

Registration Number: NCT01005810

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Phase 1

Completed

Conditions: Non Small Cell Lung Cancer (NSCLC)
Soft Tissue Sarcoma
Renal Cancer

Interventions: Drug: Panobinostat (LBH589), Sorafenib

First Posted Date: 2009-11-01

Last Posted Date: 2017-03-03

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 38

Registration Number: NCT01005797

Locations: 🇺🇸
Medical University of South Carolina Hollings Cancer Center, Charleston, South Carolina, United States

Risk Reduction for Drug Use and Sexual Revictimization

Not Applicable

Completed

Conditions: Risk Reduction Through Family Therapy
Usual Care

Interventions: Behavioral: Risk Reduction through Family Therapy

First Posted Date: 2009-10-20

Last Posted Date: 2018-06-18

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 135

Registration Number: NCT00998153

Locations: 🇺🇸
National Crime Victims Research and Treatment Center, Charleston, South Carolina, United States

Gender Differences in Response to Cues in Cocaine Dependence

Completed

Conditions: Cocaine Dependence

First Posted Date: 2009-09-02

Last Posted Date: 2018-05-07

Lead Sponsor: Medical University of South Carolina

Registration Number: NCT00969943

Locations: 🇺🇸
MUSC-Clinical Neurosciences Division, Charleston, South Carolina, United States

Determinants of Fetal Inflammatory Exposure at Term

Completed

Conditions: Maternal-Fetal Relations

First Posted Date: 2009-09-02

Last Posted Date: 2009-10-12

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 618

Registration Number: NCT00970151

Locations: 🇺🇸
Medical Univeristy of South Carolina, Charleston, South Carolina, United States

Gender Differences in Response to Nicotine Replacement Therapy and De-Nicotinized Cigarettes

Phase 2

Completed

Conditions: Nicotine Dependence

Interventions: Drug: nicotine patch (Nicoderm Committed Quitter (CQ), Habitrol)
Other: denicotinized cigarettes (Quest 3 cigarettes)

First Posted Date: 2009-08-18

Last Posted Date: 2018-10-23

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 33

Registration Number: NCT00960778

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine

Not Applicable

Withdrawn

Conditions: Bipolar Disorder
Schizophrenia

Interventions: Other: Placebo
Dietary Supplement: Green Tea

First Posted Date: 2009-07-08

Last Posted Date: 2018-07-18

Lead Sponsor: Medical University of South Carolina

Registration Number: NCT00934908

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy